Kendall Capital Management grew its stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 4.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 38,872 shares of the pharmacy operator’s stock after purchasing an additional 1,700 shares during the period. Walgreens Boots Alliance makes up approximately 1.8% of Kendall Capital Management’s portfolio, making the stock its 10th biggest holding. Kendall Capital Management’s holdings in Walgreens Boots Alliance were worth $2,292,000 at the end of the most recent reporting period.
Several other large investors also recently added to or reduced their stakes in the company. Taylor Hoffman Wealth Management grew its holdings in Walgreens Boots Alliance by 360.0% during the third quarter. Taylor Hoffman Wealth Management now owns 460 shares of the pharmacy operator’s stock worth $25,000 after acquiring an additional 360 shares during the period. Quest Capital Management Inc. ADV acquired a new position in Walgreens Boots Alliance during the third quarter worth $31,000. Simon Quick Advisors LLC grew its holdings in Walgreens Boots Alliance by 79.0% during the fourth quarter. Simon Quick Advisors LLC now owns 716 shares of the pharmacy operator’s stock worth $42,000 after acquiring an additional 316 shares during the period. Sound Income Strategies LLC grew its holdings in Walgreens Boots Alliance by 180.0% during the fourth quarter. Sound Income Strategies LLC now owns 840 shares of the pharmacy operator’s stock worth $50,000 after acquiring an additional 540 shares during the period. Finally, Golden State Wealth Management LLC grew its holdings in Walgreens Boots Alliance by 67.6% during the third quarter. Golden State Wealth Management LLC now owns 1,180 shares of the pharmacy operator’s stock worth $65,000 after acquiring an additional 476 shares during the period. 60.48% of the stock is currently owned by institutional investors and hedge funds.
WBA traded down $1.26 during trading on Friday, reaching $52.04. 6,390,245 shares of the stock were exchanged, compared to its average volume of 5,090,602. The business’s 50 day moving average price is $57.06 and its two-hundred day moving average price is $55.61. The company has a debt-to-equity ratio of 1.34, a current ratio of 0.66 and a quick ratio of 0.31. The company has a market capitalization of $47.22 billion, a price-to-earnings ratio of 12.79, a P/E/G ratio of 1.36 and a beta of 0.90. Walgreens Boots Alliance Inc has a 1 year low of $49.03 and a 1 year high of $74.94.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Wednesday, January 8th. The pharmacy operator reported $1.37 EPS for the quarter, missing the Zacks’ consensus estimate of $1.40 by ($0.03). The firm had revenue of $34.34 billion for the quarter, compared to analysts’ expectations of $34.45 billion. Walgreens Boots Alliance had a return on equity of 21.76% and a net margin of 2.69%. The firm’s revenue for the quarter was up 1.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.46 earnings per share. On average, analysts anticipate that Walgreens Boots Alliance Inc will post 5.87 EPS for the current year.
In other news, CAO Marco Patrick Anthony Pagni sold 234,355 shares of the company’s stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $63.16, for a total value of $14,801,861.80. Following the sale, the chief accounting officer now directly owns 13,844 shares in the company, valued at $874,387.04. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 16.91% of the stock is owned by corporate insiders.
A number of research analysts recently weighed in on WBA shares. Bank of America reaffirmed a “sell” rating and set a $50.00 price objective on shares of Walgreens Boots Alliance in a report on Thursday, January 2nd. Mizuho reaffirmed a “hold” rating and set a $59.00 price objective on shares of Walgreens Boots Alliance in a report on Thursday, January 9th. Pivotal Research dropped their price objective on Walgreens Boots Alliance from $60.00 to $55.00 and set a “hold” rating on the stock in a report on Wednesday, October 30th. Wells Fargo & Co lowered Walgreens Boots Alliance from an “overweight” rating to an “equal weight” rating in a report on Wednesday, December 11th. Finally, SunTrust Banks upped their price objective on Walgreens Boots Alliance from $58.00 to $60.00 and gave the stock a “hold” rating in a report on Wednesday, December 18th. Five investment analysts have rated the stock with a sell rating and fifteen have issued a hold rating to the company’s stock. Walgreens Boots Alliance currently has a consensus rating of “Hold” and an average target price of $58.69.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Further Reading: Price to Earnings Ratio (PE) Basics
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.